September 28, 2018

September 28, 2018

Cancer patients find help, inspiration at hair salon

Tampa Bay Times – Sept. 28

There’s a little-known place beneath the operating rooms at the H. Lee Moffitt Cancer Center & Research Institute. It’s Magnolia’s, a full-service hair salon that also specializes in helping patients as they go through cancer treatments.


New study suggests cancer can be treated as a game between the treating physician and cancer cells

European Commission – Sept. 28

As quoted in a press release by the Moffitt Cancer Center, journal article co-author Dr Joel Brown said: “We can and must anticipate, steer and exploit the cancer cells’ evolutionary responses to our therapies.”


Chemotherapy Before Surgery: Which Regimen is Best for Invasive Bladder Cancer?

Cure – Sept. 27

“Treatment guidelines from a number of organizations including the American Urological Association recommend neoadjuvant chemotherapy as standard treatment for muscle-invasive bladder cancer,” according to a Moffitt Cancer Center press release.


Variant Reclassification Common After Hereditary-Cancer Genetic Testing

Oncology Learning Network – Sept. 27

Dr. Susan T. Vadaparampil from Moffitt Cancer Center, in Tampa, Florida, who has researched various aspects of VUSs, told Reuters Health by email, "Physicians who facilitate or directly deliver genetic services to patients should consider approaches within their practice setting to ensure patients are educated about the possibility and frequency of reclassification for VUS and other test results.”


USF and Moffitt Cancer Center hosting world's largest Cardio-Oncology Summit

WFLA – Sept. 27

With the new growth in downtown Tampa, including the Water Street development, USF Morsani College of Medicine and the new USF Health Heart Institute, a major, world-wide cardiology conference has chosen Moffitt Cancer Center, USF and downtown Tampa to host this year’s Global Cardio-Oncology Summit.


Non-small cell lung cancer patients see improved survival with durvalumab

MD Linx – Sept. 27

Non-small cell lung cancer (NSCLC) patients survive longer when their treatment includes durvalumab, following platinum-based chemoradiotherapy, according to research led by Moffitt Cancer Center.


Cardio-Oncology Summit

WFLA – Sept. 27

USF and Moffitt Cancer Center are on the world stage. The global cardio oncology summit shows Tampa and the two institutions to host the worldwide conference. Doctors from nearly 2 dozen countries are here for it.


Longer Survivals Move Cardiotoxicity Issues to Forefront

OncLive – Sept. 26

“We really want to change the care paradigm to be more collaborative, to emphasize that oncologists and cardiologists need to be interacting together to provide good care,” said Michael G. Fradley, MD, an attending cardiologist and electrophysiologist at Moffitt Cancer Center in Tampa, Florida. 


6 best hospitals for mothers to work for

Becker’s Hospital Review – Sept. 26

Here are the six hospitals and health systems that ranked among the 100 best companies for working mothers by Working Mother magazine for 2018:

Baptist Health South Florida (Miami)
Bon Secours Virginia Health System (Richmond)
Children's Healthcare of Atlanta
H. Lee Moffitt Cancer Center & Research Institute (Tampa, Fla.)
Northwestern Memorial HealthCare (Chicago)
WellStar Health System


Moffitt researcher awarded World Molecular Imaging Society's highest honor

News Medical – Sept. 26

Robert Gillies, Ph.D., chair of the Department of Cancer Physiology and vice chair of Radiology Research at Moffitt Cancer Center, was awarded the World Molecular Imaging Society's highest honor. 


Moffitt donation

Fox 13 – Sept. 25

Hooters corporation presented Moffitt with a check for $150,000.


Moffitt receives $150,000 donation for breast cancer awareness

Bay News 9 – Sept. 25

Hooters--the sports bar restaurant--has made a 150-thousand dollar donation to Moffitt Cancer Center for breast cancer research. 


This Medical Breakthrough Can Cure Cancer with Your Own Cells

Readers’ Digest – September

“The goal of T-cell receptor therapy is to create T cells, using a process like CAR T, that can recognize those changes and attack cancers but leave healthy cells alone,” explains Frederick L. Locke, MD, vice chair of the department of cellular immunotherapy at Moffitt Cancer Center in Tampa, Florida, and a principal investigator for the Yescarta clinical trials.


RT and Surgery Appear Equally Viable for Oropharyngeal Cancer

MedPage Today – Sept. 25

"There is a tremendous opportunity to continue to refine treatment for patients with oropharyngeal cancer, especially in the era of HPV-associated oropharyngeal cancer," Louis Harrison, MD, of the Moffitt Cancer Center in Tampa, Florida, told MedPage Today. 


Adding Durvalumab to Chemoradiation Improves OS in Unresectable Stage III NSCLC

OncLive – Sept. 25

“We’ve cured 15% to 30% of patients [with stage III, unresectable NSCLC]. But of course, we’ve been stuck with those numbers for decades. We have not been able to make any inroads to improving the outcomes of these patients for quite some time,” said Scott J. Antonia, MD, PhD, department chair of the Thoracic Oncology Department at Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida College of Medicine.


Hooters Celebrates 35th Anniversary At Power Boat Races

Patch- Sept. 25

Local calendar sales in the Clearwater and Tampa Bay area benefit the Moffitt Cancer Center.


No More Kids with Cancer Awards $220,000 to Children's Hospital of Philadelphia

Business Insider – Sept. 25

This type of treatment is currently seeing success in adult AML clinical trials demonstrated by a clinical trial at the Moffitt Cancer Center and Research Institute.


Florida Breast Cancer Foundation to hold Pink Day on Oct. 20

Orlando Sentinel –  Sept. 25

The event will feature vendors, demos, giveaways, prizes, and a special Q&A session with Dr. Eric Lau, Moffitt Cancer Center Researcher and a foundation grantee.


MLMC Florida Opening New Operations

Business Facilities – Sept. 24

“Today’s modern manufacturing companies are developing technology that makes an impact worldwide, and MLMC Florida is no exception,” said Alan F. List, MD, chairman of the Tampa Hillsborough Economic Development Corporation and president and CEO of Moffitt Cancer Center.


Recent Data Support TKI Discontinuation in Patients With CML

OncLive – Sept. 24

In an interview during the 2018 OncLive® State of the Science Summit™ on Hematologic Malignancies, Sweet, an assistant member in the Department of Malignant Hematology of Moffitt Cancer Center, shed light on these data regarding treatment discontinuation and how they impact patients with CML.


Running the Asylum

Politico – Sept. 24

The spate of legal challenges delaying Florida’s regulation of medical cannabis have left a key research partnership at the Moffitt Cancer Center unfunded, leading the state to rely on data from a major marijuana grower in setting maximum dosage limits for patients. The Coalition for Medical Marijuana Research and Education has not yet received $1.77 million that was due from the state by July 1.


‘I have never seen her as happy as when she’s riding’

The Oracle – Sept. 23

Bryanna is a member of Bulls for Moffitt, a student organization dedicated to raising awareness and promoting involvement with Moffitt Cancer Center. 


The impacts of Maria one year later

WTSP - Sept. 23

After a few weeks, Torres made the decision to leave Puerto Rico with Colon after his doctor recommended he start treatment at Moffitt Cancer Center.


When the Brain Goes Haywire

Orlando Medical News – Sept. 23

Leena Kamat, MD, is a board-certified diagnostic radiologist, sub-specialized in breast imaging for Radiology Specialists of Florida at Florida Hospital. She earned her medical degree at the University of Florida, College of Medicine and following graduation completed her residency at the University of South Florida and a fellowship in breast imaging at the Moffitt Cancer Center. 


Famed Tampa lawyer Barry Cohen dies after battle with cancer

WTSP – Sept. 22

Cohen had been treated at Moffitt Cancer Center for Myelodysplastic Syndrome and later developed leukemia.


When Prostate Cancer Returns

Citrus County Chronicle – Sept. 21

But less talked about is that there is a 20 to 30 percent chance of the cancer returning, according to the Moffitt Cancer Institute. Other studies suggest the percent may be as high as 50 percent, according to the National Cancer Institute.



Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.